These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15876924)

  • 1. Economic burden of pertussis and the impact of immunization.
    Caro JJ; Getsios D; Payne K; Annemans L; Neumann PJ; Trindade E
    Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S48-54. PubMed ID: 15876924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Summary: health and economic burden of pertussis.
    Greenberg DP; Caro JJ
    Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S55-7. PubMed ID: 15876926
    [No Abstract]   [Full Text] [Related]  

  • 3. Pertussis immunization of adolescents in the United States: an economic evaluation.
    Caro JJ; Getsios D; El-Hadi W; Payne K; O'Brien JA
    Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S75-82. PubMed ID: 15876932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis in adolescents and adults: should we vaccinate?
    Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
    Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil.
    Sartori AMC; de Soárez PC; Fernandes EG; Gryninger LCF; Viscondi JYK; Novaes HMD
    Vaccine; 2016 Mar; 34(13):1531-1539. PubMed ID: 26899375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The health and economic burden of pertussis in Canada: A microsimulation study.
    McGirr A; Fisman DN; Tuite AR
    Vaccine; 2019 Nov; 37(49):7240-7247. PubMed ID: 31585727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic analysis of pertussis illness in the Dutch population: implications for current and future vaccination strategies.
    de Greeff SC; Lugnér AK; van den Heuvel DM; Mooi FR; de Melker HE
    Vaccine; 2009 Mar; 27(13):1932-7. PubMed ID: 19368774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of pertussis.
    Tan T; Trindade E; Skowronski D
    Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S10-8. PubMed ID: 15876918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pertussis immunization in the global pertussis initiative North American region: recommended strategies and implementation considerations.
    Tan T; Halperin S; Cherry JD; Edwards K; Englund JA; Glezen P; Greenberg D; Rothstein E; Skowronski D
    Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S83-6. PubMed ID: 15876933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pertussis immunization in the global pertussis initiative European region: recommended strategies and implementation considerations.
    Wirsing von König CH; Campins-Marti M; Finn A; Guiso N; Mertsola J; Liese J
    Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S87-92. PubMed ID: 15876934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic models for health economic assessments of pertussis vaccines: what goes around comes around...
    Rozenbaum MH; De Cao E; Westra TA; Postma MJ
    Expert Rev Vaccines; 2012 Dec; 11(12):1415-28. PubMed ID: 23252386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic considerations for pertussis booster vaccination in adolescents.
    Hay JW; Ward JI
    Pediatr Infect Dis J; 2005 Jun; 24(6 Suppl):S127-33. PubMed ID: 15931140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pertussis sources of infection and routes of transmission in the vaccination era.
    Schellekens J; von König CH; Gardner P
    Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S19-24. PubMed ID: 15876919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boostrix: a reduced-dose acellular pertussis vaccine for use in adolescents and adults.
    Li WC; Wu TZ; Huang YC; Huang LM
    Expert Rev Vaccines; 2009 Oct; 8(10):1317-27. PubMed ID: 19803753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of a pertussis vaccination programme for Japan considering intergenerational infection.
    Itatani T; Shimizu S; Iwasa M; Ohkusa Y; Hayakawa K
    Vaccine; 2013 Jun; 31(27):2891-7. PubMed ID: 23570987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The global pertussis initiative: process overview.
    Plotkin S
    Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S7-9. PubMed ID: 15876931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the Evidence for Maternal Pertussis Immunization: A Report From the Bill & Melinda Gates Foundation Symposium on Pertussis Infant Disease Burden in Low- and Lower-Middle-Income Countries.
    Sobanjo-Ter Meulen A; Duclos P; McIntyre P; Lewis KD; Van Damme P; O'Brien KL; Klugman KP
    Clin Infect Dis; 2016 Dec; 63(suppl 4):S123-S133. PubMed ID: 27838664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of Tdap vaccination of adults aged ≥65 years in the prevention of pertussis in the US: a dynamic model of disease transmission.
    McGarry LJ; Krishnarajah G; Hill G; Masseria C; Skornicki M; Pruttivarasin N; Arondekar B; Roiz J; Pelton SI; Weinstein MC
    PLoS One; 2014; 9(1):e72723. PubMed ID: 24416118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pertussis immunization in the global pertussis initiative international region: recommended strategies and implementation considerations.
    Forsyth K; Nagai M; Lepetic A; Trindade E
    Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S93-7. PubMed ID: 15876935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.